The abstracts summarize initial study data from using the CLS TRANBERG® Thermal Therapy System, with US-fusion image-guidance and treatment control using temperature probes, in the ongoing studies.

Both abstracts provide the latest insights into the clinical use of focal laser ablation for prostate cancer, contributing to the ongoing development of minimally invasive cancer therapies. The abstracts are now publicly available and can be accessed here.

Dr Blascke et al conclude that “FLA for prostate cancer appears to be feasible and safe, providing promising oncological control in localized prostate cancer. The procedure was well-tolerated and could be a valuable addition to focal therapy options for prostate cancer.”

The conclusion by Dr Henry and Dr Bailly was that “FLA appears effective for treating anterior and lateral prostate areas in localized cancer (ISUP 1 or 2), with minimal side effects. The technique is faster and more cost-effective than MRI-guided methods, offering comparable outcomes with real-time temperature control and reliable safety margins.”